Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Elias

Showing results (411-420 of 475) with videos related to

Pageof 48
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
Status of high-dose chemotherapy for breast cancer: a reviewY Nieto, R E Champlin, J R Wingard, et al.
Cancer|November 24, 2020
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcomaNeeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Differences in clinical trial patient attributes and outcomes according to enrollment settingElizabeth B Lamont, Mary Beth Landrum, Nancy L Keating, et al.
Plos One|February 25, 2017
Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?C Honoré, V Atallah, O Mir, et al.
Blood|July 29, 1998
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk populationP G Richardson, A D Elias, A Krishnan, et al.
American Heart Journal|August 21, 2021
The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and ObjectivesDongngan T Truong, Felicia L Trachtenberg, Gail D Pearson, et al.
Breast Cancer Research : BCR|August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancerJennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
The Canadian Journal of Cardiology|January 10, 2023
Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in ChildrenJustin Lin, Ashraf S Harahsheh, Geetha Raghuveer, et al.
Lancet (London, England)|June 14, 2016
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trialWilliam D Tap, Robin L Jones, Brian A Van Tine, et al.
Blood|October 24, 2002
Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcomePaul G Richardson, Carol Murakami, Zhezhen Jin, et al.
Pageof 48

Showing results (411-420 of 475) with videos related to

Sort By:
Pageof 48
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
Status of high-dose chemotherapy for breast cancer: a reviewY Nieto, R E Champlin, J R Wingard, et al.
Cancer|November 24, 2020
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcomaNeeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Differences in clinical trial patient attributes and outcomes according to enrollment settingElizabeth B Lamont, Mary Beth Landrum, Nancy L Keating, et al.
Plos One|February 25, 2017
Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?C Honoré, V Atallah, O Mir, et al.
Blood|July 29, 1998
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk populationP G Richardson, A D Elias, A Krishnan, et al.
American Heart Journal|August 21, 2021
The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and ObjectivesDongngan T Truong, Felicia L Trachtenberg, Gail D Pearson, et al.
Breast Cancer Research : BCR|August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancerJennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
The Canadian Journal of Cardiology|January 10, 2023
Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in ChildrenJustin Lin, Ashraf S Harahsheh, Geetha Raghuveer, et al.
Lancet (London, England)|June 14, 2016
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trialWilliam D Tap, Robin L Jones, Brian A Van Tine, et al.
Blood|October 24, 2002
Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcomePaul G Richardson, Carol Murakami, Zhezhen Jin, et al.
Pageof 48